Diamonds and Dogs
Johnson & Johnson (JNJ) trading up thanks to a positive drug trial. Johnson & Johnson is up 1.5% to a six month high after announcing results of new subgroup analysis from landmark phase 3 CREDENCE study -- INVOKANA which significantly reduced the risk of major cardiovascular events and kidney failure in patients with type 2 diabetes and chronic kidney disease.
Dave & Buster's Entertainment (PLAY) not having any fun. The restaurant chain known for their arcade of games is down 20% following lower guidance for the quarter and full year. Management is saying they have delivered robust revenue and earnings growth, but comparable-store sales were below expectations largely due to the Easter shift. Investors and the analyst community were not happy. As one analyst put it, investor confidence has been rattled and they believe it will take several quarters for management to rebuild.